Polymorphisms in the caspase-8 gene and the risk of lung cancer

Cancer Genetics and Cytogenetics

Volumn 169, Issue 2, 2006, Pages 121-127

  Son, Ji Woong ^a   Kang, Hyo Kyung ^b   Chae, Myung Hwa ^b   Choi, Jin Eun ^b   Park, Jung Min ^b   Lee, Won Kee ^c   Kim, Chang Ho ^d   Kim, Dong Sun ^b   Kam, Sin ^b   Kang, Young Mo ^c   Park, Jae Yong ^a,c  

^a Konyang University College of Medicine   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Kyungpook National University   (South Korea)

^d Kyungpook National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; KOREA; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; CASE-CONTROL STUDIES; CASPASE 8; CASPASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 33747833736     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.04.001     Document Type: Article

References (36)

1. Shields P.G., and Harris C.C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18 18 (2000) 2309-2315
2. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
3. Raff M. Cell suicide for beginners. Nature 396 (1998) 119-122
4. Shivapurkar N., Reddy J., Chaudhary P.M., and Gazdar A.F. Apoptosis and lung cancer: a review. J Cell Biochem 88 (2003) 885-898
5. Hajra K.M., and Liu J.R. Apoptosome dysfunction in human cancer. Apoptosis 9 (2004) 691-704
6. Nicholson D.W., and Thornberry N.A. Caspases: killer proteases. Trends Biochem Sci 22 (1997) 299-306
7. Budihardjo I., Oliver H., Lutter M., Luo X., and Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15 (1999) 269-290
8. Degterev A., Boyce M., and Yuan J. A decade of caspases. Oncogene 22 (2003) 8543-8567
9. Ashkenazi A., and Dixit V.M. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11 (1999) 255-260
10. Bodmer J.L., Holler N., Reynard S., Vinciguerra P., Schneider P., Juo P., Blenis J., and Tschopp J. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2 (2000) 241-243
11. Juo P., Kuo C.J., Yuan J., and Blenis J. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 8 (1998) 1001-1008
12. Kischkel F.C., Lawrence D.A., Tinel A., LeBlanc H., Virman A., Schow P., Gazdar A., Blenis J., Arnott D., and Ashkenazi A. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 276 (2001) 46639-46646
13. Sun T., Miao X., Zhang X., Tan W., Xiong P., and Lin D. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous cell carcinoma. J Natl Cancer Inst 96 (2004) 1030-1036
14. Zhang X., Miao X., Sun T., Tan W., Qu S., Xiong P., Zhou Y., and Lin D. Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J Med Genet 42 (2005) 479-484
15. MacPherson G., Healey C.S., Teare M.D., Balasubramanian S.P., Reed M.W.R., Pharoah P.D.P., Pnder B.A.J., Meuth M., Bhattacharyya N.P., and Cox A. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 24 (2004) 1866-1869
16. Lee S.J., Jeon H.S., Jang J.S., Park S.H., Lee G.Y., Lee B.H., Kim C.H., Kang Y.M., Lee W.K., Kam S., Park R.W., Kim I.S., Cho Y.L., Jung T.H., and Park J.Y. DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 26 (2005) 403-409
17. Lee G.Y., Jang J.S., Lee S.Y., Jeon H.S., Kim K.M., Choi J.E., Park J.M., Chae M.H., Lee W.K., Kam S., Kim I.S., Lee J.T., Jung T.H., and Park J.Y. XPC polymorphisms and lung cancer risk. Int J Cancer 115 (2005) 807-813
18. Jang J.S., Lee S.J., Choi J.E., Cha S.I., Lee E.B., Park T.I., Kim C.H., Lee W.K., Kam S., Choi J.Y., Kang Y.M., Park R.W., Kim I.S., Cho Y.L., Jung T.H., Han S.B., and Park J.Y. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomark Prev 14 (2005) 2474-2480
19. Lewontin R.C. On measures of gametic disequilibrium. Genetics 120 (1988) 849-852
20. Stephens M., Smith M.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
21. Risch N.J. Searching for genetic determinants in the new millennium. Nature 405 (2000) 847-856
22. Rebbeck T.R., Ambrosone C.B., Bell D.A., Chanock S.J., Hayes R.B., Kadlubar F.F., and Thomas D.C. SNPs, haplotypes, and cancer: applications in molecular epidemiology. Cancer Epidemiol Biomark Prev 13 (2004) 681-687
23. Deutsch-Wenzel R., Brune H., Grimmer G., Dettbarn G., and Misfeld J. Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polyaromatic hydrocarbons. J Natl Cancer Inst 71 (1983) 539-544
24. Hoffman D., Rivenson A., and Murphys S.E. Cigarette smoking and adenocarcinoma of the lung: the relevance of nicotine-derived nitrosamines. J Smoking Relat Disord 4 (1993) 165-190
25. Gu J., Spitz M.R., Yang F., and Wu X. Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk. Carcinogenesis 20 (1999) 1465-1469
26. Liu G., Miller D.P., Zhou W., Thurston S.W., Fan R., Xu L.L., Lynch T.J., Wain J.C., Su L., and Christianin D.C. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung cancer. Cancer Res 61 (2001) 8718-8722
27. Lee S.J., Lee S.Y., Jeon H.S., Park S.H., Jang J.S., Lee G.Y., Son J.W., Kim C.H., Lee W.K., Kam S., Park R.W., Park T.I., Kang Y.M., Kim I.S., Jung T.H., and Park J.Y. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomark Prev 14 (2005) 571-575
28. Soini Y., Paakko P., and Lehto V.P. Histopathological evaluation of apoptosis in cancer. Am J Pathol 153 (1998) 1041-1053
29. Joseph B., Ekedahl J., Sirzen F., Lewensohn R., and Zhivotovsky B. Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma. Biochem Biophys Res Commun 262 (1999) 381-387
30. Shivapurkar N., Toyooka S., Eby M.T., Huang C.X., Sathyanarayana U.G., Cunningham H.T., Reddy J.L., Brambilla E., Takahashi T., Minna J.D., Chaudhary P.M., and Gazdar A.F. Differential inactivation of caspase-8 in lung cancers. Cancer Biol Ther 1 (2002) 65-69
31. Shivapurkar N., Reddy J., Matta H., Sathyanarayana U.G., Huang C.X., Toyooka S., Minna J.D., Chaudhary P.M., and Gazdar A.F. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. Oncogene 21 (2002) 8510-8514
32. Scaffidi C., Medema J.P., Krammer P.H., and Peter M.E. FLOCE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem 272 (1997) 26953-26958
33. Eckhart L., Henry M., Santos-Beneit A.M., Schmitz I., Krueger A., Fischer H., Bach J., Ban J., Kirchhoff S., Krammer P.H., Mollinedo F., and Tschachler E. Alternative splicing of caspase-8 mRNA during differentiation of human leukocytes. Biochm Biophys Res Commun 289 (2001) 777-781
34. Himeji D., Horiuchi T., Tsukamoto H., Hayashi K., Watanabe T., and Harada M. Characterization of caspase-8L: a novel isoform of caspase-8 that behaves as an inhibitor of the caspase cascade. Blood 99 (2002) 4070-4078
35. Breckenridge D.G., Nguyen M., Kuppig S., Beth M., and Shore G.C. The procaspase-8 isoform, procaspase-8L, recruited to the BAP31 complex at the endoplasmic reticulum. Proc Natl Acad Sci U S A 99 (2002) 4331-4336
36. Wang L.E., Cheng L., Spitz M.R., and Wei Q. FAS A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. Lung Cancer 42 (2003) 1-8